Conexeu Sciences Inc (CNXU)

$16.84 +2.72 (19.26%)
Market Cap 296.29M
Revenue (ttm) 0.00
Net Income (ttm) -3.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 288,900
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 25.27M
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A
tbud929
tbud929 Jun. 2 at 11:27 AM
$CNXU Just flashed $22.50 across Schwab!
1 · Reply
BioResearcher
BioResearcher Jun. 2 at 2:43 AM
$CNXU Only $ 8 mils in cash ? and 35 mils shares on fully diluted ??? It seems they need to raise money !
0 · Reply
topstockalerts
topstockalerts Jun. 2 at 2:02 AM
$CNXU the stock is behaving like supply is drying up.
0 · Reply
red75
red75 Jun. 2 at 12:43 AM
$CNXU watching
0 · Reply
topstockalerts
topstockalerts Jun. 2 at 12:25 AM
$CNXU there’s a noticeable lack of urgency from sellers.
0 · Reply
321rip
321rip May. 31 at 6:35 PM
$CNXU looks like a breakaway gap off Fri. LO on higher vol.
0 · Reply
Matte123
Matte123 May. 29 at 2:28 PM
$CNXU Not “if”… WHEN this one gets some volume, it’s all over 💥⬆️🐆👀🤫
0 · Reply
MadMaverick
MadMaverick May. 29 at 1:55 PM
$CNXU — REGENERATIVE MEDICINE PLATFORM + TISSUE REGENERATION 👇 Conexeu Sciences is changing the game in surgery. Instead of permanent implants, they’ve developed a collagen scaffold that helps your body grow its own living tissue back. It’s a versatile, IP-protected platform for wound care and reconstruction. What’s standing out: 🔹 One Platform: Tech scales from wound care to 3D-printed breast reconstruction. Partnerships: Teaming up with Wake Forest (WFIRM) on the B.R.E.A.S.T.™ program. 🔹 Clean IP: Patents held globally with no royalty burdens. 🔹 Clear Path: Targeting 510(k) approval by early 2027. Communicated Disclaimer - https://stockresearchtoday.com/cnxu/ $PRFX $REPL $GOVX
0 · Reply
BioTuesdays
BioTuesdays May. 28 at 3:24 PM
$CNXU has initiated a preclinical development program for B.R.E.A.S.T. (BIO-REGENERATIVE ERGONOMICALLY ARCHITECTED SMART TISSUE), its recently unveiled 3D-printed bioregenerative breast matrix, at the Wake Forest Institute for Regenerative Medicine (WFIRM). https://biotuesdays.com/2026/05/28/conexeu-launches-preclinical-program-for-b-r-e-a-s-t-with-wfirm/
0 · Reply
Victory777777
Victory777777 May. 27 at 10:48 PM
$SIDU $ASTC $CNXU $SIDU $TE $WULF
1 · Reply
Latest News on CNXU
UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine

May 27, 2026, 10:36 AM EDT - 6 days ago

UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine

Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine

May 27, 2026, 8:30 AM EDT - 6 days ago

Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine

Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"

May 21, 2026, 12:02 PM EDT - 12 days ago

Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"

Conexeu Sciences opens at $13.50 after Nasdaq direct listing

2026-05-21T15:45:30.000Z - 12 days ago

Conexeu Sciences opens at $13.50 after Nasdaq direct listing

Conexeu Sciences Slides: Corporate presentation

May 11, 2026, 7:00 AM EDT - 22 days ago

Conexeu Sciences Slides: Corporate presentation

Conexeu Sciences Registration statement: Registration filing

Apr 17, 2026, 8:00 AM EDT - 6 weeks ago

Conexeu Sciences Registration statement: Registration filing

Conexeu Sciences Registration statement: Registration filing

Apr 10, 2026, 8:00 AM EDT - 7 weeks ago

Conexeu Sciences Registration statement: Registration filing

Conexeu Sciences Registration statement: Registration filing

Apr 6, 2026, 8:00 AM EDT - 2 months ago

Conexeu Sciences Registration statement: Registration filing

Conexeu Sciences Registration statement: Registration filing

Mar 26, 2026, 8:00 AM EDT - 2 months ago

Conexeu Sciences Registration statement: Registration filing

Conexeu Sciences Registration statement: Registration filing

Mar 5, 2026, 7:00 AM EST - 3 months ago

Conexeu Sciences Registration statement: Registration filing

Conexeu Sciences Registration statement: Registration filing

Feb 3, 2026, 7:00 AM EST - 4 months ago

Conexeu Sciences Registration statement: Registration filing

Conexeu Sciences Registration statement: Registration filing

Nov 28, 2025, 7:00 AM EST - 6 months ago

Conexeu Sciences Registration statement: Registration filing

tbud929
tbud929 Jun. 2 at 11:27 AM
$CNXU Just flashed $22.50 across Schwab!
1 · Reply
BioResearcher
BioResearcher Jun. 2 at 2:43 AM
$CNXU Only $ 8 mils in cash ? and 35 mils shares on fully diluted ??? It seems they need to raise money !
0 · Reply
topstockalerts
topstockalerts Jun. 2 at 2:02 AM
$CNXU the stock is behaving like supply is drying up.
0 · Reply
red75
red75 Jun. 2 at 12:43 AM
$CNXU watching
0 · Reply
topstockalerts
topstockalerts Jun. 2 at 12:25 AM
$CNXU there’s a noticeable lack of urgency from sellers.
0 · Reply
321rip
321rip May. 31 at 6:35 PM
$CNXU looks like a breakaway gap off Fri. LO on higher vol.
0 · Reply
Matte123
Matte123 May. 29 at 2:28 PM
$CNXU Not “if”… WHEN this one gets some volume, it’s all over 💥⬆️🐆👀🤫
0 · Reply
MadMaverick
MadMaverick May. 29 at 1:55 PM
$CNXU — REGENERATIVE MEDICINE PLATFORM + TISSUE REGENERATION 👇 Conexeu Sciences is changing the game in surgery. Instead of permanent implants, they’ve developed a collagen scaffold that helps your body grow its own living tissue back. It’s a versatile, IP-protected platform for wound care and reconstruction. What’s standing out: 🔹 One Platform: Tech scales from wound care to 3D-printed breast reconstruction. Partnerships: Teaming up with Wake Forest (WFIRM) on the B.R.E.A.S.T.™ program. 🔹 Clean IP: Patents held globally with no royalty burdens. 🔹 Clear Path: Targeting 510(k) approval by early 2027. Communicated Disclaimer - https://stockresearchtoday.com/cnxu/ $PRFX $REPL $GOVX
0 · Reply
BioTuesdays
BioTuesdays May. 28 at 3:24 PM
$CNXU has initiated a preclinical development program for B.R.E.A.S.T. (BIO-REGENERATIVE ERGONOMICALLY ARCHITECTED SMART TISSUE), its recently unveiled 3D-printed bioregenerative breast matrix, at the Wake Forest Institute for Regenerative Medicine (WFIRM). https://biotuesdays.com/2026/05/28/conexeu-launches-preclinical-program-for-b-r-e-a-s-t-with-wfirm/
0 · Reply
Victory777777
Victory777777 May. 27 at 10:48 PM
$SIDU $ASTC $CNXU $SIDU $TE $WULF
1 · Reply
MarketMaestro1
MarketMaestro1 May. 27 at 9:55 PM
If you had $100,000 to invest, which stocks would you most like to invest in? $SIDU $CNXU $ASTC $WULF $TE This list leans heavily into small/mid-cap growth plays. SIDU and CNXU could ride biotech or tech catalysts, while ASTC offers niche exposure in space/satellite tech. WULF and TE bring industrial and semiconductor angles. Risk is high, but upside is too. Curious what others would prioritize if investing $100K today — tech, biotech, or industrial?
0 · Reply
stocks_2watch
stocks_2watch May. 27 at 5:47 PM
$CNXU Interview— The Future of Regenerative Aesthetics, take a Look: https://www.youtube.com/watch?v=FJUXvMrH5hU
0 · Reply
jcooptechit
jcooptechit May. 26 at 4:30 PM
$CNXU JUST HIT NASDAQ | REGENERATIVE MEDICINE WATCHLIST ALERT Conexeu Sciences is now trading on Nasdaq under CNXU, advancing its proprietary CXU tissue regeneration platform. Here's The Alpha: 🔹 Nasdaq listing milestone 🔹 Patented CXU ECM platform 🔹 B.R.E.A.S.T. 3D-bioprinted regenerative breast matrix 🔹 Ten Minute Tissue injectable ECM Targeting wound care, aesthetics, GLP-1 tissue loss, periodontal care, biofabrication & vet markets CNXU is positioning around a big idea: helping the body restore lost or damaged tissue, not just replace it. This is one to watch early. ⚡️ Communicated - Disclaimer: https://stockresearchtoday.com/cnxu/ Sector Peers: $ORGO $MDXG $MDWD $HUMA
0 · Reply
theflynews
theflynews May. 26 at 3:12 PM
Opening Day: SpaceX submits S-1 for Nasdaq IPO - $CNXU - https://thefly.com/CNXU
0 · Reply
BullTradeFinder
BullTradeFinder May. 26 at 1:55 PM
$CNXU checks a lot of boxes: • Fresh IPO • Regenerative medicine story • Proprietary platform • Global patents • Massive upside potential Communicated-Disclaimer https://stockresearchtoday.com/cnxu/
0 · Reply
TheRealShortSqueezy
TheRealShortSqueezy May. 26 at 1:37 PM
$CNXU : Building Tissue Instead of Replacing It Conexeu Sciences is a regenerative medicine company developing its proprietary CXU platform to help the body naturally repair and regenerate tissue. Recent milestones and catalysts: ✅ Commenced trading on Nasdaq under ticker $ CNXU, bringing a newly public regenerative medicine story to the market ✅ Advancing its proprietary CXU platform with a one platform, multiple indications strategy spanning tissue repair, wound care, aesthetics, reconstruction and regenerative applications ✅ Building on more than a decade of research originating from the University of British Columbia and wound healing research programs CNXU isn’t chasing a single indication. It’s building across markets projected in the tens of billions, including a $17.8B advanced wound care opportunity and a regenerative medicine market expected to exceed $22B. Communicated Disclaimer: https://stockresearchtoday.com/cnxu/ Sector Peers: $MDXG $IART $ARX
0 · Reply
JTE_Theta
JTE_Theta May. 26 at 1:26 PM
🧬 $CNXU The biotech sleeping on your watchlist One platform. Five mult billion dollar markets. Conexeu has developed the CXU scaffold - a collagen based extracellular matrix that supports tissue regeneration across: 🩹 Wound care 💉 Aesthetics 🦷 Oral health 🐾 Animal health 🖨️ 3D bioprinting THE TECHNOLOGY The CXU scaffold works in 3 phases: • Repopulate - multi-cell migration • Remodel - native tissue architecture • Regenerate - tissue mirroring native structure THE MOAT Patents granted in 🇺🇸 🇪🇺 🇯🇵 🇦🇺 They own their IP outright. THE TEAM CEO Miles Harrison - scaled Galderma CSO Dr. Chavez Munoz -40+ peer-reviewed papers, 6 tissue engineering programs CMO Dr. Pilcher - 25 patents in ECM biology, 15 clinical programs in regenerative aesthetics KEY NUMBERS 💰 •$12.4M raised to date • University of British Columbia investor • $7.7M total assets • 510(k) FDA submission - Q1 FY2027 • Nasdaq: $CNXU CommunicatedDisclaimer:http://stockresearchtoday.com/cnxu/
0 · Reply
The_Titan_Traders
The_Titan_Traders May. 26 at 1:23 PM
$CNXU • Fresh Nasdaq IPO with low float momentum setup • Regenerative medicine + bioengineered tissue repair story is massive • Proprietary CXU™ platform could disrupt traditional tissue reconstruction markets • Tiny valuation compared to long-term biotech TAM potential • Any FDA progress, partnership, or clinical catalyst could send this flying • Early-stage disruptive biotech runners can go parabolic fast once momentum hits • Already starting to attract trader attention after debut • High risk/high reward setup with explosive upside potential if narrative catches fire *promo* Communicated-Disclaimer: https://stockresearchtoday.com/cnxu/
0 · Reply
IPOtweet
IPOtweet May. 22 at 10:49 PM
US IPO Weekly Recap: SpaceX files papers for what could be the largest IPO in history $SPCX $LCLN $AMSS $CNXU $OHACU $IPO #IPO https://zpr
0 · Reply
MyThoughtsExactly
MyThoughtsExactly May. 22 at 2:51 AM
$CNXU Don’t forget $4 private placement reference = early holders sitting on a 3x+ paper gain and absolutely some of them hit sell.
1 · Reply
newsfile_corp
newsfile_corp May. 21 at 4:03 PM
https://nfne.ws/298401 $CNXU #Chemicals #Pharmaceutical #HealthCare #Medical #Pharmaceuticals #NewListing #NASDAQ #Investing
0 · Reply
Telemetry1129
Telemetry1129 May. 21 at 3:24 PM
$CNXU this company is the hedge to Glp’s…it’s the only tissue regeneration company platform available…it’s very early but they are skating where the puck is headed !!
1 · Reply